Molecular Basket Trial In Multiple Malignancies With Common Target Pathway Aberrancies
Latest Information Update: 21 May 2022
Price :
$35 *
At a glance
- Drugs Panitumumab (Primary) ; Trametinib (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 12 May 2022 Status changed from active, no longer recruiting to completed.
- 01 Sep 2020 Planned End Date changed from 1 Dec 2020 to 1 Aug 2021.
- 01 Sep 2020 Planned primary completion date changed from 1 Jun 2020 to 1 Aug 2021.